BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29266591)

  • 1. Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease.
    Lee C; Betensky RA;
    Stat Med; 2018 Mar; 37(6):914-932. PubMed ID: 29266591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of covariate-specific time-dependent ROC curves in the presence of missing biomarkers.
    Li S; Ning Y
    Biometrics; 2015 Sep; 71(3):666-76. PubMed ID: 25891918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data.
    Li K; Luo S
    Stat Med; 2019 Oct; 38(24):4804-4818. PubMed ID: 31386218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold regression to accommodate a censored covariate.
    Qian J; Chiou SH; Maye JE; Atem F; Johnson KA; Betensky RA
    Biometrics; 2018 Dec; 74(4):1261-1270. PubMed ID: 29933515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing quantile-varying covariate effects under the accelerated failure time model.
    Reeder HT; Lee KH; Haneuse S
    Biostatistics; 2024 Apr; 25(2):449-467. PubMed ID: 36610077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint model robustness compared with the time-varying covariate Cox model to evaluate the association between a longitudinal marker and a time-to-event endpoint.
    Arisido MW; Antolini L; Bernasconi DP; Valsecchi MG; Rebora P
    BMC Med Res Methodol; 2019 Dec; 19(1):222. PubMed ID: 31795933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating survival times to simulate Cox proportional hazards models with time-varying covariates.
    Austin PC
    Stat Med; 2012 Dec; 31(29):3946-58. PubMed ID: 22763916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive hazards model with time-varying coefficients and imaging predictors.
    Yang Q; Wang C; He H; Zhou X; Song X
    Stat Methods Med Res; 2023 Feb; 32(2):353-372. PubMed ID: 36451621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian analysis for partly linear Cox model with measurement error and time-varying covariate effect.
    Pan A; Song X; Huang H
    Stat Med; 2022 Oct; 41(23):4666-4681. PubMed ID: 35899596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease.
    Li K; Luo S
    Stat Methods Med Res; 2019 Feb; 28(2):327-342. PubMed ID: 28750578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional proportional hazard cure rate model for interval-censored data.
    Shi H; Ma D; Faisal Beg M; Cao J
    Stat Methods Med Res; 2022 Jan; 31(1):154-168. PubMed ID: 34806480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression analysis of additive hazards model with sparse longitudinal covariates.
    Sun Z; Cao H; Chen L
    Lifetime Data Anal; 2022 Apr; 28(2):263-281. PubMed ID: 35147908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.
    Petrella JR; Hao W; Rao A; Doraiswamy PM
    Comput Math Methods Med; 2019; 2019():6216530. PubMed ID: 30863455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
    J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
    Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
    Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cox regression model with doubly truncated data.
    Rennert L; Xie SX
    Biometrics; 2018 Jun; 74(2):725-733. PubMed ID: 29073330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling unmeasured baseline information in observational time-to-event data subject to delayed study entry.
    Stegherr R; Beyersmann J; Bramlage P; Bluhmki T
    Stat Methods Med Res; 2023 May; 32(5):1021-1032. PubMed ID: 36924264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional survival forests for multivariate longitudinal outcomes: Dynamic prediction of Alzheimer's disease progression.
    Lin J; Li K; Luo S
    Stat Methods Med Res; 2021 Jan; 30(1):99-111. PubMed ID: 32726189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.